vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and New Fortress Energy Inc. (NFE). Click either name above to swap in a different company.
New Fortress Energy Inc. is the larger business by last-quarter revenue ($326.2M vs $185.2M, roughly 1.8× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -259.7%, a 260.6% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -7.0%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-134.8M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -26.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.
FOLD vs NFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $326.2M |
| Net Profit | $1.7M | $-847.1M |
| Gross Margin | 85.7% | 35.5% |
| Operating Margin | 8.6% | -193.0% |
| Net Margin | 0.9% | -259.7% |
| Revenue YoY | 23.7% | -7.0% |
| Net Profit YoY | -88.5% | -277.4% |
| EPS (diluted) | $0.00 | $-3.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $326.2M | ||
| Q3 25 | $169.1M | $240.3M | ||
| Q2 25 | $154.7M | $228.1M | ||
| Q1 25 | $125.2M | $384.9M | ||
| Q4 24 | $149.7M | $350.7M | ||
| Q3 24 | $141.5M | $446.0M | ||
| Q2 24 | $126.7M | $291.2M | ||
| Q1 24 | $110.4M | $609.5M |
| Q4 25 | $1.7M | $-847.1M | ||
| Q3 25 | $17.3M | $-263.0M | ||
| Q2 25 | $-24.4M | $-546.5M | ||
| Q1 25 | $-21.7M | $-175.4M | ||
| Q4 24 | $14.7M | $-224.4M | ||
| Q3 24 | $-6.7M | $9.3M | ||
| Q2 24 | $-15.7M | $-88.9M | ||
| Q1 24 | $-48.4M | $54.1M |
| Q4 25 | 85.7% | 35.5% | ||
| Q3 25 | 88.5% | 18.1% | ||
| Q2 25 | 90.2% | 8.4% | ||
| Q1 25 | 90.7% | 21.4% | ||
| Q4 24 | 90.1% | 17.6% | ||
| Q3 24 | 90.6% | 27.1% | ||
| Q2 24 | 91.1% | 23.8% | ||
| Q1 24 | 87.7% | 62.4% |
| Q4 25 | 8.6% | -193.0% | ||
| Q3 25 | 20.3% | -37.4% | ||
| Q2 25 | -6.1% | -170.3% | ||
| Q1 25 | -6.3% | -3.3% | ||
| Q4 24 | 10.7% | 65.0% | ||
| Q3 24 | 15.3% | 17.8% | ||
| Q2 24 | 11.8% | 12.3% | ||
| Q1 24 | -25.1% | 30.4% |
| Q4 25 | 0.9% | -259.7% | ||
| Q3 25 | 10.2% | -109.4% | ||
| Q2 25 | -15.8% | -239.6% | ||
| Q1 25 | -17.3% | -45.6% | ||
| Q4 24 | 9.8% | -64.0% | ||
| Q3 24 | -4.8% | 2.1% | ||
| Q2 24 | -12.4% | -30.5% | ||
| Q1 24 | -43.9% | 8.9% |
| Q4 25 | $0.00 | $-3.03 | ||
| Q3 25 | $0.06 | $-0.96 | ||
| Q2 25 | $-0.08 | $-1.99 | ||
| Q1 25 | $-0.07 | $-0.65 | ||
| Q4 24 | $0.05 | $-1.10 | ||
| Q3 24 | $-0.02 | $0.03 | ||
| Q2 24 | $-0.05 | $-0.42 | ||
| Q1 24 | $-0.16 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $226.5M |
| Total DebtLower is stronger | $392.7M | $8.2B |
| Stockholders' EquityBook value | $274.2M | $182.6M |
| Total Assets | $949.9M | $10.6B |
| Debt / EquityLower = less leverage | 1.43× | 44.78× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $226.5M | ||
| Q3 25 | $263.8M | $145.2M | ||
| Q2 25 | $231.0M | $551.1M | ||
| Q1 25 | $250.6M | $447.9M | ||
| Q4 24 | $249.9M | $492.9M | ||
| Q3 24 | $249.8M | $90.8M | ||
| Q2 24 | $260.1M | $133.0M | ||
| Q1 24 | $239.6M | $143.5M |
| Q4 25 | $392.7M | $8.2B | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | $8.9B | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $182.6M | ||
| Q3 25 | $230.4M | $1.1B | ||
| Q2 25 | $204.3M | $1.3B | ||
| Q1 25 | $193.6M | $1.8B | ||
| Q4 24 | $194.0M | $1.9B | ||
| Q3 24 | $178.8M | $1.6B | ||
| Q2 24 | $132.5M | $1.6B | ||
| Q1 24 | $130.7M | $1.7B |
| Q4 25 | $949.9M | $10.6B | ||
| Q3 25 | $868.8M | $12.0B | ||
| Q2 25 | $815.3M | $12.0B | ||
| Q1 25 | $789.8M | $13.1B | ||
| Q4 24 | $785.0M | $12.9B | ||
| Q3 24 | $786.6M | $12.0B | ||
| Q2 24 | $749.5M | $11.4B | ||
| Q1 24 | $721.8M | $10.9B |
| Q4 25 | 1.43× | 44.78× | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | 4.74× | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $-76.2M |
| Free Cash FlowOCF − Capex | $16.0M | $-134.8M |
| FCF MarginFCF / Revenue | 8.6% | -41.3% |
| Capex IntensityCapex / Revenue | 0.2% | 18.0% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $-1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $-76.2M | ||
| Q3 25 | $35.7M | $-171.0M | ||
| Q2 25 | $-26.5M | $-329.0M | ||
| Q1 25 | $7.8M | $-7.2M | ||
| Q4 24 | $-3.9M | $445.3M | ||
| Q3 24 | $-23.0M | $-20.0M | ||
| Q2 24 | $22.7M | $113.9M | ||
| Q1 24 | $-29.7M | $63.0M |
| Q4 25 | $16.0M | $-134.8M | ||
| Q3 25 | $35.3M | $-231.6M | ||
| Q2 25 | $-28.9M | $-726.7M | ||
| Q1 25 | $7.5M | $-262.3M | ||
| Q4 24 | $-4.2M | $-210.3M | ||
| Q3 24 | $-23.3M | $-367.0M | ||
| Q2 24 | $21.6M | $-493.2M | ||
| Q1 24 | $-31.5M | $-457.9M |
| Q4 25 | 8.6% | -41.3% | ||
| Q3 25 | 20.9% | -96.4% | ||
| Q2 25 | -18.7% | -318.6% | ||
| Q1 25 | 6.0% | -68.2% | ||
| Q4 24 | -2.8% | -60.0% | ||
| Q3 24 | -16.5% | -82.3% | ||
| Q2 24 | 17.0% | -169.3% | ||
| Q1 24 | -28.5% | -75.1% |
| Q4 25 | 0.2% | 18.0% | ||
| Q3 25 | 0.2% | 25.2% | ||
| Q2 25 | 1.6% | 174.4% | ||
| Q1 25 | 0.2% | 66.3% | ||
| Q4 24 | 0.2% | 187.0% | ||
| Q3 24 | 0.3% | 77.8% | ||
| Q2 24 | 0.9% | 208.4% | ||
| Q1 24 | 1.6% | 85.5% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | -2.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
NFE
Segment breakdown not available.
